A

Ambys Medicines

28 employees

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2018

Funding rounds raised

Total raised

$60M

from 6 investors over 6 rounds

A

Ambys Medicines raised $47M on December 21, 2021

Investors: Schroders Capital, Smilegate Investment, Laurion Capital Management LP and Third Rock Ventures

A

Ambys Medicines raised $60M on August 8, 2018

Investors: Third Rock Ventures and Takeda UK Limited

FAQ